PEG/Polysorbate Skin Testing Has No Utility in the Assessment of Suspected Allergic Reactions to SARS-CoV-2 Vaccines
- PMID: 34393075
- PMCID: PMC8324467
- DOI: 10.1016/j.jaip.2021.06.025
PEG/Polysorbate Skin Testing Has No Utility in the Assessment of Suspected Allergic Reactions to SARS-CoV-2 Vaccines
Keywords: COVID-19; PEG; SARS-CoV2 vaccine; Sensitivity; Shared decision-making; Skin testing; Specificity; Vaccine reaction.
Comment in
-
Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines.J Allergy Clin Immunol Pract. 2023 Feb;11(2):666. doi: 10.1016/j.jaip.2022.11.029. J Allergy Clin Immunol Pract. 2023. PMID: 36759085 Free PMC article. No abstract available.
Comment on
-
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22. J Allergy Clin Immunol Pract. 2021. PMID: 34166844 Free PMC article.
References
-
- Greenhawt M., Abrams E., Shaker M., Chu D., Kahn D., Akin C. The risk of allergic reactions to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. [published online ahead of print June 18, 2021]. J Allergy Clin Immunol Pract. - DOI - PMC - PubMed
-
- Mahase E. Covid-19: people with history of significant allergic reactions should not receive Pfizer vaccine, says regulator. BMJ. 2020;371:m4780. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous